What does CUSIP 01438T106 represent in this 13F holders report?

CUSIP 01438T106 is the security identifier for ALDX - Aldeyra Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held ALDX - Aldeyra Therapeutics, Inc. - Common Stock in Q4 2014?

5 institutional investors reported ALDX - Aldeyra Therapeutics, Inc. - Common Stock for Q4 2014. Use the holders table for investor-level position and value details.

Aldeyra Therapeutics, Inc. - Common Stock (ALDX)

CUSIP: 01438T106

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class: Equity / Common Stock
Shares outstanding: 59,794,743
Total 13F shares: 870,129
Share change: +11,713
Total reported value: $6,277,000
Price per share: $7.18
Number of holders: 5
Value change: +$82,000
Number of buys: 2
Number of sells: 2

Quarterly Holders Quick Answers

What is CUSIP 01438T106?
CUSIP 01438T106 identifies ALDX - Aldeyra Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2015
Previous quarter: Q3 2014

Recent filing periods for CUSIP 01438T106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ALDX - Aldeyra Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	1.4%	834,811	$5,017,000	—	30 Sep 2014	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.04%	22,558	$135,000	—	30 Sep 2014	13F
UBS AG	13F	Company	0%	921	$5,000	—	30 Sep 2014	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	414	$2,000	—	30 Sep 2014	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0%	364	$2,000	—	30 Sep 2014	13F
BlackRock Investment Management, LLC	13F	Company	0%	269	$2,000	—	30 Sep 2014	13F

Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock (ALDX) as of Q4 2014

As of 31 Dec 2014, Aldeyra Therapeutics, Inc. - Common Stock (ALDX) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 870,129 shares. The largest 5 holders included FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, Spark Investment Management LLC, MORGAN STANLEY, and BlackRock Investment Management, LLC. This page lists 5 institutional shareholders reporting positions in this security for the Q4 2014 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2014 vs Q3 2014 Across Filers

Q3 2014 holders

Q4 2014 holders

Holder diff

-1

Investor	Q3 2014 Shares	Q4 2014 Shares	Share Diff	Share Chg %	Q3 2014 Value $	Q4 2014 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.